Jiangbo Pharmaceuticals, Inc.
SEC CIK 1091164 · JGBO · last insider filing 2011-06-07
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Zhou George | Director | filed 2011 - 2011 |
| Wang John | Director | filed 2008 - 2010 |
| Cao Wubo | Director · CEO, President | filed 2008 - 2010 |
| Marks Michael | Director | filed 2008 - 2010 |
| Arboleda Rodrigo | Director | filed 2008 - 2008 |
| Ge Jian | Director | filed 2008 - 2008 |
| Huang Lei | Director | filed 2008 - 2008 |
| Feng Xiaowei | Director | filed 2008 - 2008 |
| Zhang Yihua | Director | filed 2008 - 2008 |
| Xu Haibo | Director · COO, Vice President | filed 2008 - 2008 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Sung Elsa | Chief Financial Officer | filed 2008 - 2010 |
| Jin Linxian | Chief Executive Officer | filed 2010 - 2010 |
| Xue Hong | Controller | filed 2008 - 2008 |
| Xin Jingsheng | Director of Equipment | filed 2008 - 2008 |
| Yang Weidong | VP, Director of Sales | filed 2008 - 2008 |
| Dong Lining | VP, Director of Technology | filed 2008 - 2008 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.